Literature DB >> 12208964

Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

Phalguni Gupta1, Kelly B Collins, Deena Ratner, Simon Watkins, Gregory J Naus, Daniel V Landers, Bruce K Patterson.   

Abstract

The virologic and cellular factors that are involved in transmission of human immunodeficiency virus type 1 (HIV-1) across the female genital tissue are poorly understood. We have recently developed a human cervical tissue-derived organ culture model to study heterosexual transmission of HIV-1 that mimics the in vivo situation. Using this model we investigated the role of phenotypic characteristics of HIV-1 and identified the cell types that are first infected during transmission. Our data indicate that the cell-free R5 HIV-1 was more efficiently transmitted than cell-free X4 HIV-1. Cell-free and cell-associated HIV-1 had comparable transmission efficiency regardless of whether the virus was of R5 or X4 type. We have demonstrated that memory CD4(+) T cells and not Langerhans cells were the first HIV-1 RNA-positive cells detected at the epithelial-submucosal junction 6 h after virus exposure. Multicolor laser confocal microscopy demonstrated a globular distribution of HIV-1 gag-pol mRNA in the cytoplasm, and the distribution of CD4 and the CD45RO isoform was irregular on the cellular membrane. At 96 h postinoculation, in addition to memory CD4(+) T cells, HIV-1 RNA-positive Langerhans cells and macrophages were also detected. The identification of CD4(+) T cells in the tissue at 6 h was confirmed by flow cytometric simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization assay on immune cells isolated from disaggregated tissue. Furthermore, PMPA [9-[2-(phosphonomethoxy)propyl] adenine], an antiretroviral compound, and UC781, a microbicide, inhibited HIV-1 transmission across the mucosa, indicating the utility of the organ culture to screen topical microbicides for their ability to block sexual transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208964      PMCID: PMC136513          DOI: 10.1128/jvi.76.19.9868-9876.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques.

Authors:  P Silvera; P Racz; K Racz; N Bischofberger; C Crabbs; J Yalley-Ogunro; J Greenhouse; J B Jiang; M G Lewis
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-20       Impact factor: 2.205

2.  Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

Authors:  P Greenhead; P Hayes; P S Watts; K G Laing; G E Griffin; R J Shattock
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation.

Authors:  B K Patterson; M A Czerniewski; J Pottage; M Agnoli; H Kessler; A Landay
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

4.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

5.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.

Authors:  P Gupta; C Leroux; B K Patterson; L Kingsley; C Rinaldo; M Ding; Y Chen; K Kulka; W Buchanan; B McKeon; R Montelaro
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

7.  9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; J M Cherrington; M L Marthas; P D Lamy; P J Dailey; D R Canfield; R P Tarara; N Bischofberger; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

Authors:  H Zhang; G Dornadula; M Beumont; L Livornese; B Van Uitert; K Henning; R J Pomerantz
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

9.  Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.

Authors:  J Balzarini; L Naesens; E Verbeken; M Laga; L Van Damme; M Parniak; L Van Mellaert; J Anné; E De Clercq
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

10.  Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.

Authors:  T Kawamura; S S Cohen; D L Borris; E A Aquilino; S Glushakova; L B Margolis; J M Orenstein; R E Offord; A R Neurath; A Blauvelt
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  68 in total

1.  Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.

Authors:  Héloïse Quillay; Hicham El Costa; Romain Marlin; Marion Duriez; Claude Cannou; Fabrice Chrétien; Hervé Fernandez; Anne Lebreton; Julien Ighil; Olivier Schwartz; Françoise Barré-Sinoussi; Marie-Thérèse Nugeyre; Elisabeth Menu
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Antiretroviral therapy as HIV prevention: status and prospects.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.

Authors:  Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

Review 4.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

5.  Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Authors:  Phalguni Gupta; Deena Ratner; Ming Ding; Bruce Patterson; Lisa C Rohan; Todd A Reinhart; Velpandi Ayyavoo; Xioli Huang; Dorothy L Patton; Bharat Ramratnam; Alexander M Cole
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

6.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

7.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

8.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.

Authors:  Mauro Pistello; Donatella Matteucci; Francesca Bonci; Patrizia Isola; Paola Mazzetti; Lucia Zaccaro; Antonio Merico; Daniela Del Mauro; Norman Flynn; Mauro Bendinelli
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.

Authors:  Charlene S Dezzutti; Florian Hladik
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 10.  HIV infection of the genital mucosa in women.

Authors:  Florian Hladik; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.